These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 9081729)
1. [Analysis of the mechanism of the development of insulin-dependent diabetes mellitus and an attempt to prevent its onset by the functional T cell molecules]. Yokono K; Nagata M; Moriyama K; Tsukamoto K; Miki M; Yoneda R; Tominaga Y; Okamoto N; Yasuda N; Amano K; Kasuga M; Yagita H; Okumura Y Nihon Rinsho Meneki Gakkai Kaishi; 1996 Dec; 19(6):618-21. PubMed ID: 9081729 [No Abstract] [Full Text] [Related]
3. Pancreatic IL-4 expression results in islet-reactive Th2 cells that inhibit diabetogenic lymphocytes in the nonobese diabetic mouse. Gallichan WS; Balasa B; Davies JD; Sarvetnick N J Immunol; 1999 Aug; 163(3):1696-703. PubMed ID: 10415077 [TBL] [Abstract][Full Text] [Related]
4. [Recombinant human IGF-1 prevents type 1 diabetes in female non-obese diabetic mice]. Liu F; Yu M; Zhu Q Zhonghua Yu Fang Yi Xue Za Zhi; 2000 Sep; 34(5):281-3. PubMed ID: 11372396 [TBL] [Abstract][Full Text] [Related]
5. The use of a non-depleting anti-CD4 monoclonal antibody to re-establish tolerance to beta cells in NOD mice. Hutchings P; O'Reilly L; Parish NM; Waldmann H; Cooke A Eur J Immunol; 1992 Jul; 22(7):1913-8. PubMed ID: 1623929 [TBL] [Abstract][Full Text] [Related]
6. I-Ag7-mediated antigen presentation by B lymphocytes is critical in overcoming a checkpoint in T cell tolerance to islet beta cells of nonobese diabetic mice. Noorchashm H; Lieu YK; Noorchashm N; Rostami SY; Greeley SA; Schlachterman A; Song HK; Noto LE; Jevnikar AM; Barker CF; Naji A J Immunol; 1999 Jul; 163(2):743-50. PubMed ID: 10395666 [TBL] [Abstract][Full Text] [Related]
7. Progression of spontaneous autoimmune diabetes is associated with a switch in the killing mechanism used by autoreactive CTL. Qin H; Trudeau JD; Reid GS; Lee IF; Dutz JP; Santamaria P; Verchere CB; Tan R Int Immunol; 2004 Nov; 16(11):1657-62. PubMed ID: 15466911 [TBL] [Abstract][Full Text] [Related]
8. Transfusion of apoptotic beta-cells induces immune tolerance to beta-cell antigens and prevents type 1 diabetes in NOD mice. Xia CQ; Peng R; Qiu Y; Annamalai M; Gordon D; Clare-Salzler MJ Diabetes; 2007 Aug; 56(8):2116-23. PubMed ID: 17496235 [TBL] [Abstract][Full Text] [Related]
9. Peptide-pulsed immature dendritic cells reduce response to beta cell target antigens and protect NOD recipients from type I diabetes. Lo J; Peng RH; Barker T; Xia CQ; Clare-Salzler MJ Ann N Y Acad Sci; 2006 Oct; 1079():153-6. PubMed ID: 17130547 [TBL] [Abstract][Full Text] [Related]
10. Short administration of polyclonal anti-T cell antibody (ALS) in NOD mice with extensive insulitis prevents subsequent development of autoimmune diabetes. Ogawa N; Minamimura K; Kodaka T; Maki T J Autoimmun; 2006 Jun; 26(4):225-31. PubMed ID: 16713179 [TBL] [Abstract][Full Text] [Related]
11. CD8(+) T cells specific for beta cells encounter their cognate antigens in the islets of NOD mice. Pang S; Zhang L; Wang H; Yi Z; Li L; Gao L; Zhao J; Tisch R; Katz JD; Wang B Eur J Immunol; 2009 Oct; 39(10):2716-24. PubMed ID: 19658094 [TBL] [Abstract][Full Text] [Related]
12. A novel mechanism of regulatory T cell-mediated down-regulation of autoimmunity. Qin HY; Mukherjee R; Lee-Chan E; Ewen C; Bleackley RC; Singh B Int Immunol; 2006 Jul; 18(7):1001-15. PubMed ID: 16675487 [TBL] [Abstract][Full Text] [Related]
13. [Molecular mechanisms of pancreatic beta-cell destruction in IDDM]. Imagawa A; Hanafusa T; Imagawa A Nihon Rinsho; 1997 Oct; 55 Suppl():288-92. PubMed ID: 9392122 [No Abstract] [Full Text] [Related]
14. Comparing the relative role of perforin/granzyme versus Fas/Fas ligand cytotoxic pathways in CD8+ T cell-mediated insulin-dependent diabetes mellitus. Kreuwel HT; Morgan DJ; Krahl T; Ko A; Sarvetnick N; Sherman LA J Immunol; 1999 Oct; 163(8):4335-41. PubMed ID: 10510373 [TBL] [Abstract][Full Text] [Related]
15. The frequency and immunodominance of islet-specific CD8+ T-cell responses change after type 1 diabetes diagnosis and treatment. Martinuzzi E; Novelli G; Scotto M; Blancou P; Bach JM; Chaillous L; Bruno G; Chatenoud L; van Endert P; Mallone R Diabetes; 2008 May; 57(5):1312-20. PubMed ID: 18305140 [TBL] [Abstract][Full Text] [Related]
16. Isolation of self antigen-reactive cells from inflamed islets of nonobese diabetic mice using CD4high expression as a marker. Lejon K; Fathman CG J Immunol; 1999 Nov; 163(10):5708-14. PubMed ID: 10553102 [TBL] [Abstract][Full Text] [Related]
17. Induction of glutamic acid decarboxylase 65-specific Th2 cells and suppression of autoimmune diabetes at late stages of disease is epitope dependent. Tisch R; Wang B; Serreze DV J Immunol; 1999 Aug; 163(3):1178-87. PubMed ID: 10415012 [TBL] [Abstract][Full Text] [Related]
18. Characterisation of CD8 monoclonal antibody-induced protection from diabetes in NOD mice. Parish N; Cooke A Autoimmunity; 2005 Dec; 38(8):597-604. PubMed ID: 16390812 [TBL] [Abstract][Full Text] [Related]
19. Cytotoxic T lymphocyte and cDNA sequence analyses of the MHC class Ib molecule Qa1 in nonobese diabetic mice. Chun T; Hermel E; Gaskins HR; Aldrich CJ Immunogenetics; 2001 Aug; 53(6):506-10. PubMed ID: 11685462 [No Abstract] [Full Text] [Related]
20. Progression of autoimmune diabetes driven by avidity maturation of a T-cell population. Amrani A; Verdaguer J; Serra P; Tafuro S; Tan R; Santamaria P Nature; 2000 Aug; 406(6797):739-42. PubMed ID: 10963600 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]